Cell & Gene Therapies

iStock/Michail_Petrov-96

Alexion ends Moderna mRNA pact

By Flora Southey

Alexion Pharmaceuticals says it is reducing R&D operations and terminating mRNA-focused preclinical partnerships.

Follow us

Products

View more

Webinars